Tech Company Financing Transactions
Porton Advanced Solutions Funding Round
China Merchants Group, China Merchants Securities and China Merchants Venture Capital invested in a $80 million Series B capital raise for Porton Advanced Solutions. The round closed on 8/22/2022.
Transaction Overview
Company Name
Announced On
8/22/2022
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Series B
Investors
Proceeds Purpose
The company will use the proceeds to continue its business expansion into different markets, with investment in core manufacturing infrastructures and in global commercial operations.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Building 3 Ascendas Park No.388 Xinping St Suzhou Industrial
Jiangsu, 215021
CN
Jiangsu, 215021
CN
Phone
Website
Email Address
Overview
Porton Advanced Solutions (Porton Advanced) is a Cell and Gene Therapy (CGT) CDMO. We provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services to meet clients' therapeutic product needs at pre-clinical, clinical, and commercial stages.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Wang Yangzhou
Browse more venture capital transactions:
Prev: 8/22/2022: Myplanet venture capital transaction
Next: 8/22/2022: Highline venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs